Several miRNAs including miR-146a, miR-204-5p, miR-211-5p, miR-550a-3-6p, miR-199b-5p, miR-126-3p, and miR-204-5p have been proven to contribute to melanoma resistance to BRAF inhibitors or/and MARK inhibitors [93,94,95,96,97]. This evidence concerns the gene BRAF and melanoma.